Skip to main content
Clinical Trials/NCT02729064
NCT02729064
Unknown
Phase 1

Effect of Intranasal Insulin Administration on Glycaemia and Insulin Concentrations in Plasma and Cerebrospinal Fluid During Surgery

Hiroaki Sato, MD., PhD.1 site in 1 country141 target enrollmentSeptember 2016

Overview

Phase
Phase 1
Intervention
Humulin R
Conditions
Ischemic Heart Disease
Sponsor
Hiroaki Sato, MD., PhD.
Enrollment
141
Locations
1
Primary Endpoint
Cerebrospinal Fluid Insulin
Last Updated
5 years ago

Overview

Brief Summary

Intranasal insulin is reported to improves memory performance in patients suffering from cognitive impairment. The investigators have previously shown that intraoperative insulin administration preserves both short and long-term memory function after cardiac surgery. Applying intranasal insulin bypasses blood-brain barrier and cause elevation of insulin concentrations in the cerebrospinal fluid without major effects on peripheral insulin level. Patients undergoing major surgery are exposed to carbohydrate and insulin metabolism alteration. The goal of the study is to study the effect of intranasal insulin on blood glucose, plasma and cerebrospinal insulin concentration in patients undergoing cardiac surgery or endovascular thoracic aneurysm repair.

Detailed Description

Clinical trials have demonstrated that intranasal insulin improves both memory performance and metabolic integrity of the brain in patients suffering from Alzheimer's disease or cognitive impairment. A single dose of intranasal insulin acutely improved memory in memory-impaired older adults. Cognitive impairment in post-operative period is an increasing problem as more elderly patients undergo major surgery. The investigators have previously shown that intraoperative insulin administration while maintaining normoglycaemia preserves both short and long-term memory function after open heart surgery. Applying insulin as a nasal spray bypasses blood-brain barrier and cause significant and sustained elevation of insulin concentrations in the cerebrospinal fluid (CSF) without major effects on peripheral insulin levels. The administration of 40 IU of intranasal insulin(INI) rapidly increases CSF insulin concentration within seven minutes, peaking after 30 minutes and remaining elevated for more than 80 minutes. Presently it is not clear if CNS insulin plays a relevant role in controlling blood glucose in humans. Patients undergoing major surgery are exposed to metabolic and endocrine alterations in carbohydrate, protein, and insulin metabolism, often summarized as the catabolic stress response. While the effect of intravenous insulin on glucose metabolism during surgery has been extensively studied the influence of intranasal insulin administration on intraoperative plasma insulin and blood glucose concentrations is unknown. Goal and Objectives The goal of the present study is to study the effect of intranasal insulin on * blood glucose and plasma insulin concentrations in patients undergoing elective cardiac surgery * blood glucose, plasma insulin and cerebrospinal insulin concentration in patients undergoing elective endovascular thoracic aneurysm repair.

Registry
clinicaltrials.gov
Start Date
September 2016
End Date
September 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hiroaki Sato, MD., PhD.
Responsible Party
Sponsor Investigator
Principal Investigator

Hiroaki Sato, MD., PhD.

Assistant Professor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility Criteria

Inclusion Criteria

  • All patients (\>18 years) undergoing elective open heart surgery requiring CPB or elective endovascular thoracic aortic aneurysm repair at the RVH.

Exclusion Criteria

  • Planned use of drugs that effect plasma glucose concentration during the first four hours of surgery.
  • Patients with allergy to insulin
  • Patients with a base line blood glucose less than 3.9 mmol/L

Arms & Interventions

Intranasal 40

Patients will receive 40 IU of intranasal insulin (Humulin R) via a metered nasal dispenser

Intervention: Humulin R

Intranasal 80

Patients will receive 80 IU of intranasal insulin (Humulin R) via a metered nasal dispenser

Intervention: Humulin R

Placebo

Patients will receive intranasal normal saline via a metered nasal dispenser

Intervention: Normal Saline

Outcomes

Primary Outcomes

Cerebrospinal Fluid Insulin

Time Frame: During Surgery

Cerebrospinal Fluid will be taken every 10 to 30 minutes during the endovascular thoracic aneurysm repair surgery. Insuring concentration of Cerebrospinal fluid will be measured.

Blood Glucose

Time Frame: During Surgery

Arterial blood samples will be collected every 10 to 30 minutes during the surgery. Circulating concentrations of glucose will be measured.

Plasma Insulin

Time Frame: During Surgery

Arterial blood samples will be collected every 10 to 30 minutes during the surgery. Plasma insulin will be measured.

Study Sites (1)

Loading locations...

Similar Trials